Voie d'immunisation et séquence d'administration de l ... - TEL

tel-00827710, version 1 - 29 May 2013
Fuertes, M.B., Kacha, A.K., Kline, J., Woo, S.R., Kranz, D.M., Murphy, K.M., and Gajewski,
T.F. (2011). Host type I IFN signals are required for antitumor CD8+ T cell responses
through CD8{alpha}+ dendritic cells. J Exp Med 208, 2005-2016.
Fujii, S., Liu, K., Smith, C., Bonito, A.J., and Steinman, R.M. (2004). The linkage of innate to
adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to
antigen presentation and CD80/86 costimulation. J Exp Med 199, 1607-1618.
Gallucci, S., Lolkema, M., and Matzinger, P. (1999). Natural adjuvants: endogenous
activators of dendritic cells. Nat Med 5, 1249-1255.
Gautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J., Bates, E.E., Trinchieri, G.,
Caux, C., and Garrone, P. (2005). A type I interferon autocrine-paracrine loop is involved in
Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 201,
1435-1446.
Gea-Banacloche, J.C., Migueles, S.A., Martino, L., Shupert, W.L., McNeil, A.C., Sabbaghian,
M.S., Ehler, L., Prussin, C., Stevens, R., Lambert, L., et al. (2000). Maintenance of large
numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term
nonprogressors. J Immunol 165, 1082-1092.
Gerlach, C., van Heijst, J.W., Swart, E., Sie, D., Armstrong, N., Kerkhoven, R.M., Zehn, D.,
Bevan, M.J., Schepers, K., and Schumacher, T.N. (2010). One naive T cell, multiple fates in
CD8+ T cell differentiation. J Exp Med 207, 1235-1246.
Ginhoux, F., Collin, M.P., Bogunovic, M., Abel, M., Leboeuf, M., Helft, J., Ochando, J.,
Kissenpfennig, A., Malissen, B., Grisotto, M., et al. (2007). Blood-derived dermal langerin+
dendritic cells survey the skin in the steady state. J Exp Med 204, 3133-3146.
Gogas, H., Ioannovich, J., Dafni, U., Stavropoulou-Giokas, C., Frangia, K., Tsoutsos, D.,
Panagiotou, P., Polyzos, A., Papadopoulos, O., Stratigos, A., et al. (2006). Prognostic
significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med
354, 709-718.
Gottschalk, R.A., Hathorn, M.M., Beuneu, H., Corse, E., Dustin, M.L., Altan-Bonnet, G., and
Allison, J.P. (2012). Distinct influences of peptide-MHC quality and quantity on in vivo Tcell
responses. Proc Natl Acad Sci U S A.
Green, D.R. (2011). The end and after: how dying cells impact the living organism. Immunity
35, 441-444.
Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., Van Endert, P., and Amigorena, S.
(2003). ER-phagosome fusion defines an MHC class I cross-presentation compartment in
dendritic cells. Nature 425, 397-402.
Hadrup, S.R., Bakker, A.H., Shu, C.J., Andersen, R.S., van Veluw, J., Hombrink, P.,
Castermans, E., Thor Straten, P., Blank, C., Haanen, J.B., et al. (2009). Parallel detection of
antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat
Methods 6, 520-526.
Hasan, U.A., Caux, C., Perrot, I., Doffin, A.C., Menetrier-Caux, C., Trinchieri, G.,
Tommasino, M., and Vlach, J. (2007). Cell proliferation and survival induced by Toll-like
receptors is antagonized by type I IFNs. Proc Natl Acad Sci U S A 104, 8047-8052.
He, S., Liang, Y., Shao, F., and Wang, X. (2011). Toll-like receptors activate programmed
necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl
Acad Sci U S A 108, 20054-20059.
Heath, W.R., Belz, G.T., Behrens, G.M., Smith, C.M., Forehan, S.P., Parish, I.A., Davey,
G.M., Wilson, N.S., Carbone, F.R., and Villadangos, J.A. (2004). Cross-presentation,
Page 243 of 256